v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Statement of Cash Flows [Abstract]    
Net loss $ (24,930,687) $ (12,012,943)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 960,930 998,641
(Gain)/loss on disposal of property and equipment 19,668 (13,595)
Noncash lease expense 684,360 645,695
Bad debt expense 55,222 1,429,791
Contract modification - related party 280,545
Share-based compensation 10,280 22,675
Income tax expense 208,669
Shares issued to pay for services 129,000
Accrued interest on notes payable 803,030 937,899
Non-cash royalty income (48,668) (39,846)
Amortization of original issue discounts on notes payable 29,167
Loan origination costs 5,000 54,400
Loss on excess fair value of warrants 7,255,528
Loss on exercise of warrant liabilities 15,722,096
Changes in fair value of warrant liability 8,928,275 (2,807,890)
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables (1,534,474) 1,420,733
Trade receivables - related party 87,116 (136,277)
Inventory 1,162,286 1,350,333
Contract assets 387,056 624,141
Prepaid expenses and other current assets (98,976) 548,129
Other assets 125,035 (274,081)
Accounts payable 295,378 (1,588,439)
Accounts payable - related party (5,009)
Sales tax payable (58,449) 2,036
Operating lease liabilities (692,804) (646,595)
Deposits from customers (146,744) 189,331
Accrued expenses 60,159 (496,932)
Contract liabilities 1,455,386 921,287
Deferred revenue (135,687) (395,065)
Income taxes payable (24,582) (196,727)
Other liabilities 10,864 (201,366)
Net cash provided by/(used in) operating activities 3,410,782 (2,076,477)
Cash Flows from Investing Activities    
Purchase of property and equipment (1,435,743) (429,334)
Proceeds from sale of property and equipment 13,511 77,110
Royalties on related party revenues 40,000 46,000
Investment in MasterpieceVR (100,000) (100,000)
Net cash used by investing activities (1,482,232) (406,224)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 23,424,024 26,682,873
Payments on revolving line of credit (24,509,177) (24,025,081)
Payments on debt (985,212) (7,818,405)
Payments on Paycheck Protection Program Loans (50,628) (30,365)
Proceeds on Loan from CEO 200,000
Proceeds on bank loans 28,267
Proceeds from notes payable 500,000
Proceeds from warrant exercises 1,307,354
Proceeds from offerings 1,463,550 10,035,293
Expenses on offerings (232,100) (935,333)
Purchases of treasury stock (69,705)
Net cash provided by financing activities 1,117,811 3,867,544
Effect of currency translation (321,394) (114,180)
Net increase/(decrease) in cash, cash equivalents, and restricted cash 2,724,967 1,270,663
Cash, cash equivalents, and restricted cash at beginning of period 5,420,392 6,349,562
Total cash, cash equivalents, and restricted cash 8,145,359 7,620,225
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and cash equivalents 7,032,530 6,468,197
Restricted cash 1,112,829 1,152,028
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 1,777,081 705,504
Cash paid during the period for income taxes, net of refunds 237,943 196,727
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay for services 129,000
Financing of fixed asset purchase 28,331
Noncash recognition of new leases 720,104 294,513
Series A Warrant Exercises 21,515,777
Series B Warrant Exercises $ 1,386,169